FERRARI, LUDOVICA
 Distribuzione geografica
Continente #
AS - Asia 106
NA - Nord America 104
EU - Europa 79
SA - Sud America 16
AF - Africa 1
Totale 306
Nazione #
US - Stati Uniti d'America 98
IT - Italia 37
SG - Singapore 37
BD - Bangladesh 25
BR - Brasile 13
CN - Cina 11
DE - Germania 11
HK - Hong Kong 11
RU - Federazione Russa 9
VN - Vietnam 9
NL - Olanda 7
GB - Regno Unito 5
FI - Finlandia 4
CA - Canada 3
IN - India 3
JP - Giappone 3
AR - Argentina 2
MX - Messico 2
TR - Turchia 2
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CO - Colombia 1
ES - Italia 1
FR - Francia 1
HU - Ungheria 1
IR - Iran 1
MY - Malesia 1
NI - Nicaragua 1
PK - Pakistan 1
SE - Svezia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 306
Città #
Singapore 24
San Jose 19
Ashburn 14
Rome 13
Hong Kong 9
Council Bluffs 7
Orem 6
Munich 5
New York 4
Los Angeles 3
Tokyo 3
Amsterdam 2
Beijing 2
Chicago 2
Hanoi 2
Helsinki 2
Ho Chi Minh City 2
Houston 2
Hyderabad 2
London 2
Manchester 2
Moscow 2
San Francisco 2
Santa Clara 2
Annapolis 1
Baku 1
Bandar Seri Begawan 1
Benito Juarez 1
Budapest 1
Bắc Giang 1
Cagliari 1
Cardito 1
Chennai 1
Covina 1
Cruz das Almas 1
Curitiba 1
Da Nang 1
Dallas 1
Des Moines 1
Fortaleza 1
Francisco Beltrão 1
Frankfurt am Main 1
Guarulhos 1
Haiphong 1
Hampton 1
Henrico 1
Istanbul 1
Itaperuna 1
Izmir 1
Johannesburg 1
Kuala Lumpur 1
La Banda 1
Lahore 1
Lappeenranta 1
Lauterbourg 1
Macaé 1
Managua 1
Mburucuyá 1
Medellín 1
Mexico City 1
Milan 1
Montreal 1
North Bergen 1
North Kansas City 1
Nuremberg 1
Pato Branco 1
Perugia 1
Phoenix 1
Porteirinha 1
Raleigh 1
Redondo Beach 1
Rock Springs 1
Rosário do Sul 1
Salt Lake City 1
Santa Ana 1
Santa Isabel 1
Stockholm 1
São Paulo 1
Tehran 1
Thái Bình 1
Toronto 1
Turku 1
Urussanga 1
Vancouver 1
Venice 1
Warren 1
Wilmington 1
Totale 196
Nome #
P-375. Long-Term Suppressive Antimicrobial Therapy in Prosthetic Vascular Graft Infection: a Five-Year Retrospective Evaluation 137
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 95
The evolving landscape of COVID-19: Factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance 81
Severe Mycoplasma pneumoniae Pneumonia During the 2023–2024 European Re-Emergence: Why Severity Does Not Predict Macrolide Resistance 9
Totale 322
Categoria #
all - tutte 1.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202582 0 0 13 1 0 2 20 5 19 5 12 5
2025/2026240 14 10 13 23 26 6 24 21 23 14 26 40
Totale 322